Humacyte

HUMACYTE INC

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Humacyte Inc

Humana Inc

HUMANOID GLOBAL HLDGS CP by HUMANOID GLOBAL HLDGS CORP.

Humanoid Global Holdings Corp

Humankind US Stock ETF

HUMAN PHEROMONE SCIENCE by Human Pheromone Sciences, Inc.

Human - United States dollar

HUMAN HOLDINGS CO LTD by Human Holdings Co., Ltd.

Human Holdings Co Ltd

HUMAN UNITEC INTL INC by Human Unitec International, Inc.

Human Unitec International Inc

Humanigen Inc

Humanscape

Humatech Inc

News

Health Care

Press Releases

General

Results from Humacyte's V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting

Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency

Humacyte Announces First Symvess™ Sale to Military Treatment Facility

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025

Earnings

Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update

Humacyte Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess™

Humacyte Announces Publication of Preclinical Data on Use of the CTEV as a Coronary Artery Bypass Graft (CABG)

Penny Stocks

Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus

Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess™

Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering

HUMA

Abeona Therapeutics

AC Immune

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Alector

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Cabaletta Bio

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Enanta Pharmaceuticals, Inc. - Common Stock

Enanta Pharma

Eupraxia Pharmaceuticals Inc. - Common Stock

Eupraxia Pharmaceuticals

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics

Immutep Limited - American Depositary Shares

Immutep

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Puma Biotechnology

PepGen

ProQR Therapeutics N.V. - Ordinary Shares

ProQR Therapeutics

Cartesian Therapeutics, Inc. - Common Stock

Cartesian Therapeutics

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Tenaya Therapeutics

Vanda Pharmaceuticals Inc. - Common Stock

Vanda Pharmaceuticals

Voyager Therapeutics, Inc. - Common Stock

Voyager Therapeutics

Zura Bio Limited - Class A Ordinary shares

Comments

Humacyte

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO